title: Successful multi-target therapy using corticosteroid, tacrolimus, cyclophosphamide, and rituximab for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis.
authors.affiliation: a Department of Hematology and Rheumatology , Tohoku University Graduate School of Medicine , Sendai , Japan.
authors.forename: Ryu
authors.initials: R
authors.lastname: Watanabe
authors.affiliation: a Department of Hematology and Rheumatology , Tohoku University Graduate School of Medicine , Sendai , Japan.
authors.forename: Tomonori
authors.initials: T
authors.lastname: Ishii
authors.affiliation: a Department of Hematology and Rheumatology , Tohoku University Graduate School of Medicine , Sendai , Japan.
authors.forename: Kyoko
authors.initials: K
authors.lastname: Araki
authors.affiliation: a Department of Hematology and Rheumatology , Tohoku University Graduate School of Medicine , Sendai , Japan.
authors.forename: Mariko
authors.initials: M
authors.lastname: Ishizuka
authors.affiliation: a Department of Hematology and Rheumatology , Tohoku University Graduate School of Medicine , Sendai , Japan.
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Kamogawa
authors.affiliation: a Department of Hematology and Rheumatology , Tohoku University Graduate School of Medicine , Sendai , Japan.
authors.forename: Yoko
authors.initials: Y
authors.lastname: Fujita
authors.affiliation: a Department of Hematology and Rheumatology , Tohoku University Graduate School of Medicine , Sendai , Japan.
authors.forename: Yuko
authors.initials: Y
authors.lastname: Shirota
authors.affiliation: a Department of Hematology and Rheumatology , Tohoku University Graduate School of Medicine , Sendai , Japan.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Fujii
authors.affiliation: a Department of Hematology and Rheumatology , Tohoku University Graduate School of Medicine , Sendai , Japan.
authors.forename: Hideo
authors.initials: H
authors.lastname: Harigae
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D003882:Dermatomyositis / Q000150:complications*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D017563:Lung Diseases, Interstitial / Q000150:complications / Q000188:drug therapy*; D008875:Middle Aged; D000069283:Rituximab / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D000069283:Rituximab; D003520:Cyclophosphamide; D016559:Tacrolimus
keywords: Clinically amyopathic dermatomyositis; Interstitial lung disease; Multi-target therapy; Rituximab